- Home
- BIPC vs ADMA Comparison
BIPC vs ADMA Comparison
Compare BIPC & ADMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BIPC
- ADMA
- Stock Information
- Founded
- BIPC 2019
- ADMA 2004
- Country
- BIPC United States
- ADMA United States
- Employees
- BIPC N/A
- ADMA N/A
- Industry
- BIPC Marine Transportation
- ADMA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- BIPC Consumer Discretionary
- ADMA Health Care
- Exchange
- BIPC Nasdaq
- ADMA Nasdaq
- Market Cap
- BIPC 4.7B
- ADMA 5.1B
- IPO Year
- BIPC N/A
- ADMA N/A
- Fundamental
- Price
- BIPC $41.77
- ADMA $17.03
- Analyst Decision
- BIPC
- ADMA Strong Buy
- Analyst Count
- BIPC 0
- ADMA 3
- Target Price
- BIPC N/A
- ADMA $27.67
- AVG Volume (30 Days)
- BIPC 543.9K
- ADMA 2.6M
- Earning Date
- BIPC 01-01-0001
- ADMA 08-07-2025
- Dividend Yield
- BIPC 4.14%
- ADMA N/A
- EPS Growth
- BIPC N/A
- ADMA N/A
- EPS
- BIPC N/A
- ADMA 0.84
- Revenue
- BIPC $3,693,000,000.00
- ADMA $459,381,000.00
- Revenue This Year
- BIPC $65.55
- ADMA $21.42
- Revenue Next Year
- BIPC $6.21
- ADMA $26.30
- P/E Ratio
- BIPC N/A
- ADMA $20.50
- Revenue Growth
- BIPC 26.99
- ADMA 62.23
- 52 Week Low
- BIPC $32.08
- ADMA $10.21
- 52 Week High
- BIPC $43.41
- ADMA $25.67
- Technical
- Relative Strength Index (RSI)
- BIPC 51.78
- ADMA 38.23
- Support Level
- BIPC $41.20
- ADMA $16.77
- Resistance Level
- BIPC $42.45
- ADMA $18.79
- Average True Range (ATR)
- BIPC 0.80
- ADMA 0.62
- MACD
- BIPC -0.11
- ADMA -0.04
- Stochastic Oscillator
- BIPC 34.34
- ADMA 29.98
About BIPC Brookfield Infrastructure Corporation
Brookfield Infrastructure Corp is an indirect subsidiary of the partnership of the diversified infrastructure owner and operators. Its business is comprised of a U.K. regulated distribution operation, a Brazilian regulated natural gas transmission operation and an international intermodal logistics operation. Geographically, the company generates a majority of its revenue from Brazil and rest from United Kingdom and the United States.
About ADMA ADMA Biologics Inc
ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. The segments of the company are ADMA BioManufacturing which generates maximum revenue and Plasma Collection Centres, and corporate segment. The company sells plasma-derived intermediate fractions to certain customers, which are generated as part of its FDA-approved manufacturing process for IG and IVIG products. It also provides laboratory contracting services to certain customers and anticipates providing contract filling, labeling and packing services. The company derives maximum revenue from United States.